Households facing steep bills for surgeries, chronic prescriptions, or long-term care have a federal tax break available, but only if their total unreimbursed costs clear a specific income-based threshold. Under federal law, taxpayers who itemize deductions on Schedule A can subtract qualified medical and dental expenses that exceed 7.5% of their adjusted gross income. Congress locked that 7.5% floor into permanent law through the Consolidated Appropriations Act of 2021, ending years of uncertainty over whether the threshold would revert to 10%.
How the 7.5% AGI floor shapes who benefits
The rule works like a filter. A household with $60,000 in adjusted gross income, for example, would need more than $4,500 in qualifying medical costs before any deduction kicks in. Only the amount above that line counts. The statutory text of Section 213 defines the deduction as medical care expenses “to the extent” they exceed 7.5% of AGI, making the percentage a hard floor rather than a sliding scale.
That floor matters most for people with large, concentrated expenses in a single tax year: joint replacements, cancer treatment, assisted-living costs, or insulin and specialty drugs that run into thousands of dollars per month. For someone whose costs barely graze the threshold, the deductible portion can be slim enough that taking the standard deduction still produces a lower tax bill. The practical result is that the medical expense deduction tends to reward taxpayers at two extremes: those with very high medical costs relative to income, and those who already itemize because of mortgage interest or state and local taxes.
The 2017 Tax Cuts and Jobs Act nearly doubled the standard deduction, which pulled millions of filers away from itemizing altogether. A Congressional Research Service brief on itemized deductions found that the larger standard deduction sharply reduced the number of households that itemize, limiting access to the medical deduction for many middle-income filers. That structural shift has not reversed, even as out-of-pocket health spending continues to climb.
Congress settled the threshold after years of swings
The 7.5% floor has a turbulent legislative history. The Affordable Care Act raised the threshold to 10% of AGI for most taxpayers, with a temporary exemption for filers 65 and older. Congress then passed a series of short-term extensions to keep the lower 7.5% rate in place. The back-and-forth created planning headaches for tax preparers and households trying to time elective procedures or bunch expenses into a single year.
That uncertainty ended when the Consolidated Appropriations Act of 2021 made the 7.5% floor permanent for tax years beginning after 2020. The provision, identified in legislative text as Section 101 and titled “Reduction in Medical Expense Deduction Floor,” removed the expiration date that had forced repeated congressional action. House Report 116-379 from the earlier Taxpayer Certainty and Disaster Tax Relief Act of 2019 described the policy rationale for keeping the floor at 7.5% of AGI, framing it as relief for taxpayers with significant health costs.
With the threshold now fixed in statute, filers no longer need to guess whether the floor will jump back to 10% in a future year. That stability allows better planning around large medical expenditures, though the deduction itself still requires itemizing on Schedule A and competing with the standard deduction.
What qualifies and what the IRS expects on Schedule A
The IRS spells out eligible costs in its guidance on medical and dental expenses. Qualifying charges include doctor and hospital fees, prescription drugs, certain insurance premiums not paid with pre-tax dollars, medically necessary travel, and some long-term care services. Cosmetic procedures generally do not qualify unless they address a deformity from disease, accident, or congenital condition. The filing instructions for Schedule A walk taxpayers through the math: enter total medical expenses, subtract 7.5% of AGI, and carry the remainder forward as a deduction.
Documentation is the practical barrier. The IRS expects receipts, insurance explanations of benefits, pharmacy printouts, and records showing that expenses were not reimbursed by an employer plan, health savings account, or other source. Filers who claim the deduction without adequate records risk having it disallowed in an audit, which can trigger back taxes plus interest. For households with ongoing treatment plans, keeping contemporaneous records throughout the year is often easier than trying to reconstruct spending at tax time.
Gaps in public data on who actually claims the deduction
One significant blind spot is the absence of recent, granular IRS Statistics of Income data showing how many taxpayers claim the medical expense deduction broken down by income bracket and expense category after the TCJA changes took full effect. Without that detail, it is difficult to measure precisely how many middle-income households are crossing the 7.5% threshold because of rising drug prices or chronic-condition costs versus higher-income filers who itemize for other reasons and capture the medical deduction as a secondary benefit.
Researchers and policymakers are left to infer patterns from older datasets and survey-based measures of out-of-pocket health spending. Those sources suggest that serious illness and disability tend to concentrate medical costs in a relatively small share of households, but they do not directly reveal how often those costs translate into a federal tax deduction. The lack of up-to-date administrative data limits the ability to evaluate whether the 7.5% floor is effectively targeting relief to families under financial strain from health shocks.
State-level complexity and coordination issues
State income tax systems add another layer of complexity. Some states conform closely to federal definitions of itemized deductions, including medical expenses, while others decouple from federal rules, use different percentage floors, or disallow the deduction altogether. In states that follow federal law, the 7.5% AGI floor effectively applies twice-once for federal and once for state purposes-potentially magnifying the benefit for households with very high out-of-pocket costs.
Where state rules diverge, taxpayers can face confusing trade-offs. A household might itemize at the state level to claim medical expenses but still find the federal standard deduction more advantageous, or vice versa. Differences in how states define adjusted gross income can also shift the dollar amount of the 7.5% floor. Tax preparers often need to run parallel calculations to determine whether bunching medical procedures into a single calendar year will produce meaningful tax savings across both systems.
Planning strategies and policy stakes
For households with predictable, high medical spending-such as ongoing dialysis, chemotherapy, or long-term care-there may be limited flexibility to shift expenses between years. Others, however, can sometimes schedule elective surgeries, dental work, or hearing aids in the same year as a major diagnosis or hospitalization to push total costs above the 7.5% threshold. That kind of bunching strategy only pays off if the combined itemized deductions exceed the standard deduction, underscoring how the broader tax system shapes access to this relief.
On the policy side, the fixed 7.5% floor represents a compromise between targeting aid to those with exceptional expenses and limiting the cost to the federal budget. Lowering the threshold would extend the deduction to more households with moderate medical bills, but at a fiscal cost; raising it would narrow eligibility further, concentrating the benefit among those facing the most severe financial strain from health care. Without fresher data on who claims the deduction and in what amounts, debates over changing the floor are likely to rest on partial evidence and competing assumptions about who bears the heaviest burden of out-of-pocket costs.
For now, the medical expense deduction remains a niche but important provision: inaccessible to most filers who rely on the standard deduction, yet potentially valuable for families whose health crises push their spending well beyond 7.5% of income. As medical prices and insurance designs continue to evolve, the question of whether this tax break is reaching the households it is meant to help will remain central to any future discussion of reform.
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
